Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Eve Burstein

Bernstein · covers Healthcare

Period: Reporting periods mapped to calendar 2024 Q4 – 2025 Q2 (3 quarters).

Limited coverage. Only 5 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.
Questions
5on tracked calls
Challenge rate
0%none of 5 questionsLimited sample
Companies
3questioned at least once
Reporting periods
3with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 5 of 5 questions from 3 companies

AAgilent Technologies2 questions · 1 reporting period · 0 of 2 challenging
A company page →

Calendar 2025 Q1

You said you were starting to see a little bit of softness at the end of January. How is that trending into February?

MacroeconomicRegulation PolicyTranscript · FY2025 Q1 →
Show response

Padraig indicated stable trends from January into February, not deteriorating. Wider Q2 guide range provides buffer. Direct.

Within GC, is there opportunity for an upcycle here as well? You've mentioned several times that in LC different customers, different applications

Product LaunchDemandTranscript · FY2025 Q1 →
Show response

Mike Zhang confirmed GC replacement opportunity with new GCMS launch seeing strong customer response. Described as long-term annual opportunity.

WATWaters Corporation2 questions · 1 reporting period · 0 of 2 challenging
WAT company page →

Calendar 2024 Q4

you said that the instrument replacement commercial initiative was progressing well with still 15% of lagged 2015 to 2019 replacement opportunity remaining

DemandCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Management clarified two distinct replacement drivers: cyclical catch-up and legacy 15% still tracked in CRM.

you said in response to Vijay pricing was closer to 200 bps. Just to clarify was that the contribution for growth in 4Q

Show response

CFO confirmed ~200bps like-for-like pricing contribution in 2024, consistent with 2025 guide assumption.

ILMNIllumina, Inc.1 question · 1 reporting period · 0 of 1 challenging
ILMN company page →

Calendar 2025 Q2

is it fair to say that your guidance increase for China could be quite specific to 2025

Guidance ReliabilityGeographic ExpansionTranscript · FY2025 Q2 →
Show response

Ankur confirmed the China raise is for the current quarter, not a long-term signal; Jacob saw a natural run rate, not pull-forward.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
A Agilent Technologies2—Rate withheld: fewer than 3 questions
WAT Waters Corporation2—Rate withheld: fewer than 3 questions
ILMN Illumina, Inc.1—Rate withheld: fewer than 3 questions
  • A
    Agilent Technologies · 2 questions
    —rate withheld: under 3 questions
  • WAT
    Waters Corporation · 2 questions
    —rate withheld: under 3 questions
  • ILMN
    Illumina, Inc. · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q420%none of 2 questions1
2025 Q120%none of 2 questions1
2025 Q210%none of 1 question1
  1. 2024 Q42 questions · challenge rate 0% (none of 2 questions) · 1 company
  2. 2025 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company
  3. 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Demand2
  • Guidance Reliability1
  • Geographic Expansion1
  • Macroeconomic1
  • Regulation Policy1
  • Product Launch1
  • Competitive Dynamics1
  • Pricing1